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One Sentence Summary: Glaucoma is associated with decreased neurotrophic signaling at the 
optic nerve head; an understanding of which may lead to novel therapeutic approaches to reverse 
this blockade.  
Authors: Cassidy Christopherson1*. 
Affiliations: 1South Dakota State University, cassidy.christopherson@jacks.sdstate.edu. 
Abstract: 
Glaucoma is the leading cause of irreversible blindness, and the second leading vision 
loss neurodegenerative disease affecting millions worldwide. Glaucoma is characterized as a 
group of eye disorders which are initially asymptomatic but may progress to significant optic 
nerve head damage and vision loss with time. Early stages of glaucoma often go undetected, 
leading to irreversible  damage to the optic nerve head prior to patients seeking medical care. 
Glaucoma leads to vision loss via death of retinal ganglion cells. Retinal ganglion cell apoptosis 
is thought to begin due to  interference  with the normal transmission of neurotrophic signals that 
arrive by retrograde axonal transport from target cells. The physiologic mechanism of retinal 
ganglion cell death still remains unknown, and currently no treatment to reverse the damage and 
restore vision exists. Emphasis in research has been placed on the contribution of the lamina 
cribrosa and the trans-laminar pressure differences in the pathophysiology of glaucoma. A 
growing body of evidence suggests that glaucoma occurs due to and elevated trans-laminar 
pressure difference (TLPD) secondary to an intraocular pressure and cerebrospinal fluid pressure 
imbalance. This review extensively focuses on the underlying mechanisms of axonal blockade, 
which interfere with neurotropic signaling at the optic nerve head. The review also explores 
additional mechanisms of cell death at the optic nerve head that produce optic nerve damage 
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which mimics glaucoma. Further insight and research into these areas may lead to therapeutic 
reversal of this blockade and decrease the burden of glaucoma worldwide. 
Introduction 
The second leading cause of blindness worldwide, glaucoma is a group of 
neurodegenerative diseases which lead to progressive optic neuropathy and irreversible loss of 
retinal ganglion cell (RGC) axons.1 Glaucoma costs the U.S economy an estimated $2 billion 
every year in direct costs and productivity, hence the emphasis on regular eye exams for early 
diagnosis and intervention.2 The glaucomatous optic nerve head (ONH) presents with a 
characteristic excavated appearance of the optic disk, collapse and remodeling of the lamina 
cribrosa (LC),1 and activation of astrocytes3,4.  The pathological mechanisms responsible for 
glaucoma development remain unknown. However, elevated intraocular pressure (IOP) has been 
identified as a potential causative and the only modifiable risk factor in glaucoma5. Chronic 
elevation of IOP results in optic nerve head (ONH) alterations,5 including the compression of 
retinal ganglion cell axons at the lamina cribrosa (LC), restriction of axoplasmic flow, and 
retrograde neurotrophic transport blockade to RGCs.1 Of note, patients may have elevated IOP 
and never develop glaucoma. Likewise, patients may develop glaucoma in spite of having 
normal or even low IOP. In addition to exposure to IOP, the  RGC axons are exposed at the 
ONH to intracranial pressure (ICP), which is transmitted to the optic nerve at multiple points. 
The interaction between these two pressures has been linked to the development of glaucomatous 
damage at the optic nerve head. 
The lamina cribrosa (LC) is an important mesh-like structure which resides within the 
posterior scleral opening through which RGCs exit the globe and continue as the retrobulbar 
optic nerve (ON) (See figure A-1 for diagram). The laminar plates contain precisely organized 
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extracellular matrix proteins including collagen and elastin fibers, which comprise the supportive 
framework and elasticity of the ONH. IOP- induced conformational distortion within the scleral 
lamina cribrosa results in rotation, compression, misalignment and collapse of the laminar pores 
and channels such that axoplasmic flow is reduced and ultimately blocked causing death of 
RGCs.6 Apoptotic cell death in glaucoma is initiated by interference with the transmission of 
neurotrophic signals that normally arrive by retrograde axonal transport from target cells.7  
  Various methods have been employed to elicit a complex relationship between astrocytic, 
neural and fibrous elements of the lamina cribrosa. The cribriform plates are lined by basement 
membranes consisting of fibrillar collagen and elastic fiber filled cores. Anterior to the LC, the 
ONH is subjected to IOP. Posterior to the LC, the neural tissue is exposed to the cerebrospinal 
fluid pressure (CSFp).2,4 The pressure across the LC is referred to as the translaminar pressure 
gradient (TLPD=IOP-CSFp). The difference between IOP and CSFp creates a pressure gradient 
across the LC that induces stress in the anteroposterior direction.8 The RGCs pass through the 
anterior and posterior regions of the LC and are exposed to the TLPD at the ONH. Exposure to 
the TLPD allows them to play a potential role in the development of glaucoma when 
neurotrophic signaling is reduced.9 
Methods 
A literature search conducted for the years 1981-2017 included pertinent optic nerve 
axonal transport information under normal physiological and pathophysiological conditions from 
the review of citations retrieved from Web of Science Database, EBSCO Database, National 
Library of Medicine, SciFinder Database, and PubMed Database. Complete copies of each of the 
relevant articles were obtained, and after thorough analysis each was based on the strength of the 
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study design and relation to neurotrophic signaling in glaucoma. Keywords searched included: 
glaucoma, optic nerve head, retinal degeneration, signal transduction, translaminar gradient.   
Normal Optic Nerve Characteristics 
 The prelaminar optic nerve is known as the optic disc, optic nerve head or optic papilla. 
The concentration of RGC axons into a single optic nerve makes the optic nerve an extremely 
vulnerable segment of the visual pathway.10 The optic nerve is comprised of four major regions, 
shown in figure 1.10 The intraocular optic nerve includes the retinal ganglion cell layer, the nerve 
fiber layer, the optic nerve head or optic disc and the intralaminar region within the sclera. The 
intraorbital optic nerve, intracanalicular optic nerve and the small intracranial optic nerve, which 
merges into the optic chiasm are all located posterior to the intralaminar region.10   
 
 
Figure 1. The optic cup, neuroretinal rim (NRR), nerve fiber layer (NFL), retinal ganglion cell (RGC) layer, 
choroid, sclera, and short posterior ciliary arteries (SPCA) are all illustrated. Retinal ganglion cells with cell bodies 
located near the optic disc (A), midperipheral retina (B) and peripheral retina (C) send their axons to the central, 
middle and peripheral regions of the optic disc and nerve.10  
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Physiology of the Normal Optic Nerve 
The optic nerve axons are made up of an outer sheath of myelin, a hollow, thin, 
collapsible, bilayer lipid cell wall, and a viscoelastic axoplasm containing transmitter molecules, 
proteins, microtubules and organelles.10 The axoplasm moves along an intra-axonal pressure 
gradient. Axoplasmic flow is orthograde from the RGC cell body toward the synapse but is 
retrograde from the synapse toward the RGC cell body. Mitochondria located within each axon 
segment provide the necessary metabolic energy for axoplasmic flow and are subject to ischemic 
episodes. Anterograde axoplasmic flow is for the forward movement of cargo from the cell body 
to the axon tip. In contrast, retrograde axoplasmic flow is for movement of neurotrophins and 
waste products of the retinal ganglion cells backwards to the cell body.10 Axoplasmic flow may 
be slow for purposes of cell membrane maintenance, or fast for synaptic transmission.10  
The internal ophthalmic artery is the primary source of blood flow to the eye. It branches 
into the central retinal artery and several ciliary arteries. The central retinal artery and retinal 
arterioles supply blood to the prelaminar optic nerve. The primate lamina cribrosa receives blood 
primarily from the short posterior ciliary arteries.10 Blood flow in the retina and prelaminar ONH 
circulations is autoregulated and capable of responding to IOP-induced ocular perfusion pressure 
(OPP) changes.10   
Translaminar Pressure Gradient and Role in Glaucoma  
There is significant interest in both the translaminar pressure difference (TLPD) and 
lamina cribrosa (LC) and their pathologic contribution to glaucoma. A growing body of evidence 
suggests that glaucoma occurs primarily due to an elevated TLPD, and secondarily due to an 
imbalance between IOP and CSFp. The main support for this theory originates from the two 
large retrospective studies by Berdahl et al.7,11 These studies reported that subjects with open-
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angle or normal-tension glaucoma had lower CSFp (and higher TLPD) compared to controls. 
Furthermore, subjects with ocular hypertension had elevated CSFp compared to controls and 
may be protected from developing glaucoma. Additional evidence of this theory was provided by 
a prospective study from Ren at al. evaluating subjects undergoing lumbar puncture: patients 
with NTG (9.5 ± 2.2 mmHg) had the lowest CSFp, followed by POAG (11.7 ± 2.7 mmHg) and 
then non-glaucomatous controls (12.9 ± 1.9 mmHg).12 Once a significant translaminar pressure 
gradient results in enough optic nerve damage, irreversible optic neuropathy and vision loss may 
occur.  
Retinal Ganglion Cell Characteristics 
The optic nerve is composed principally of the axons of retinal ganglion cells. Retinal 
ganglion cell axons project from the retinal nerve fiber layer through the optic chiasm and optic 
tracts to either the lateral geniculate nucleus, RGCs and their optic nerve axons provide the sole 
connection between photoreceptors of the retina and the central components of the visual 
system.10 The immature astrocytes and blood vessels enter the retina at the optic nerve head and 
colonize the entire RNF.10 RGC axons guide the formation of an astrocytic network that 
subsequently directs vessel development.13 Migrating astrocytes play an important role in the 
formation, development, and health of the retinal nerve fiber layer have been found in close 
association with the axons of RGCs. As shown in figure 2, RGCs are neighbors to astrocytes in 
the RNFL.13 RGCs are necessary to provide directional information to migrating astrocytes. 
Astrocytes exhibited polarization defects, failed to colonize the peripheral retina and display 
fine-scale spatial patterning.13 The fine-scale spatial pattern established by astrocytes is 
confirmed to be abnormal when they lack RGC guidance signals, confirming a model in which 
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RGCs are required for astrocytic colonization of the retina, and astrocytes are in turn essential for 
normal vascular development.13  
 
Figure 2. Cellular composition and development of the nerve fiber layer. Schematic image indicates 
RGCs (gray), astrocytes (green) and blood vessels (magenta). 
 
Retinal Ganglion Cells in Glaucoma 
A number of authors have recognized that glaucoma is characterized by death of retinal 
ganglion cells and by a typical excavated appearance of the optic nerve head. However, it is 
significant to note that axon apoptosis can occur in other ocular disease besides glaucoma.1,14,15 
Glaucoma is associated with reduced optic nerve axoplasmic flow and compromised circulation 
such that RGC death due to neurotrophin deprivation result.10  In a landmark study, elevated IOP 
and subsequent chronic glaucoma was induced in one eye of 12 monkeys, either by the injections 
of red blood cells (RBC) fixed in glutaraldehyde to the anterior chamber, or Aargon laser 
treatment to the trabecular meshwork.15 All 12 monkeys with induced chronic glaucoma 
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appeared to have RGCs with similar histological features including condensation of nuclear 
chromatin at the nuclear edge compatible with induced apoptosis.15  
Additionally, the retinas of 5 monkeys that underwent unilateral optic nerve transection 
were evaluated in intervals after axotomy. The findings of the study are summarized in table 1. 
In the study, at 2 and 4 weeks all 5 demonstrated abnormal ganglion cells with apoptotic bodies 
and features identical to those with induced chronic glaucoma. Remarkably, at the 10-12 week 
interval few ganglion cells remained in the retina and therefore no abnormal cells were detected 
post axotomy.15 The similarity in findings between induced glaucoma and total axotomy provide 
interesting insight into the process of retinal ganglion cell death. However, a number of questions 
regarding the mechanisms underlying development of glaucoma remain.  
 
Vascular Regulation of Optic Nerve Head Perfusion 
The vascular endothelium of the optic nerve is an active participant in the maintenance of 
vascular tone and regulation of blood flow through myogenesis (formation of muscle tissue).10 
Endothelial cells are responsible for detecting changes in the microenvironment and responding 
Table 1. Histologic Study Following Transfection of Monkey Eyes. 
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accordingly with the synthesis of various vasoactive factors to maintain the delicate balance 
between vasoconstriction and vasodilation.10 Endothelial-derived relaxing factor, prostacyclin 
(PGI2) causes increased intracellular cAMP levels in vascular smooth muscle which reduces 
intracellular calcium, induces myorelaxation, and ultimately increases optic nerve head blood 
flow.10 Endothelin-1 (ET-1) is responsible for vasoconstriction and decreasing the optic nerve 
head blood flow by increasing the release of intracellular calcium.  
Pathologic Intracellular Signaling in Retinal Ganglion Cell Apoptosis 
The survival of neurons depends on trophic signals from neighboring cells to control the 
continuous inhibition of an intrinsic apoptotic cell suicide program. The understanding of the 
stimuli that promote the survival of RGCs in vivo is therefore of critical relevance to developing 
methods to save adult RGCs from optic nerve diseases such as glaucoma which induce RGC 
death.16  Promotion of central nervous system (CNS) neuronal survival in culture appears to 
require simultaneous stimulation by converging trophic peptides. In contrast, a single peptide 
trophic factor is sufficient to inhibit apoptosis of peripheral nervous system neurons.16 The 
neurotrophic hypothesis suggests that, in vivo, the developing neurons compete for limited 
amounts of target-derived trophic factors which ultimately controls their survival.17 However, 
Shen et al. attested that the hypothesis is too simple to apply to the developing CNS because it is 
necessary for the RGCs to be depolarized in order to respond to trophic factors. The simplest 
explanation for why RGCs lose trophic responsiveness following axotomy is that their 
intracellular levels of cAMP quickly decrease.16 
The second messenger cyclic adenosine 3’,5’-monophosphate (cAMP) is a regulator of 
biological processes in the optic nerve and retina.16 cAMP levels control the trophic receptors of 
RGCs.  Responsiveness of RGCs, measured by mitogen- activated protein (MAP) kinase 
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activation, in intact retinas was found to be nearly abolished by blockade of electrical activity, by 
adenylyl cyclase inhibition, and by axotomy.16 Since physiological levels of cAMP play a critical 
role in controlling RGC response to peptide trophic factors, a decrease in cAMP levels could 
simply occur if a reduction in the activity of axotomized RGCs occurs.  
The loss of responsiveness folloing axotomy could simply be decrease in RGC activity. 
The effects of peptides and cAMP elevation on RGC survival after axotomy were further 
explored in an adult rat model.16 A calcium channel agonist, BayK8644, successfully mimicked 
the ability of CPT-cAMP to promote the survival of axotomized RGCs when combined with 
trophic factors. However, BayK8644 treatment alone did not save axotomized RGCs.16 The 
ability of RGCs to activate and translocate MAP kinase from their cytoplasm into their nucleus 
can be used to assess the RGCs trophic responsiveness in vitro. Only when RGCs cAMP levels 
were elevated did peptide trophic factor provoke the translocation of MAP kinase into the nuclei 
of RGCs.5 The treatment of the retinas with SQ22356 nearly abolished the translocation of MAP 
kinase into the nucleus according to Shen et al.  
An additional trophic factor mediator, P38 MAP kinase contributes to the progression of 
retinal ganglion cell degeneration. Although increasing age is a significant risk factor for 
glaucoma, it was hypothesized by Dapper and Calkins that the effects of age were different from 
the effects of ocular pressure on p38 MAPK activation.18 To study their hypothesis, Dapper and 
Calkins compared age naive mice to an inbred mouse model that had increases intraocular 
pressure. 18 This study found that ocular pressure plays a more significant role than advanced age 
on p38MAPK  activation in the retina of experimental glaucoma models.18 It is possible that 
again may decrease the threshold for signal pathway activation and lead to subsequent neuronal 
injury rather than by directly activating the p38 MAPK pathway.18 
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Actions of Transforming Growth Factor on Neurotrophic Signaling 
Transforming growth factor-β2 is a protein that helps with controlling cell proliferation, 
differentiation, motility and apoptosis as part of the TGF- β signaling pathway.5 Several studies 
suggest that ONH cells respond to elevated IOP by increasing TGF- β2 synthesis in the lamina 
cribrosa, which causes altered ECM protein expression.5,19,20 Following the treatment of 
dissected human ONH and LC cells with recombinant TGF- β2, TGF-β2 was found to be 
significantly increased in the LC region of the ONH in eyes with induced glaucoma compared to 
age-matched normal eyes by an immunohistochemical evaluation. This is shown in figure 3.5 
Elevated TGF-β2 levels result in the pathological deposition of ECM proteins5. The TGF-β-
dependent apoptosis signaling pathway has a critical role in glaucomatous neuropathy by 
increased synthesis and secretion of extracellular matrix(ECM) proteins and remodeling of the 
ONH.5 ONH astrocytes and LC cells secrete TGF-β2, indicating that these cells may be an in 
vivo source of TGF-β2 in the human ONH.5,19–21  Chronic elevation of IOP induces ONH 
changes including retinal ganglion cell axon compression at the LC and axoplasmic flow and 
neurotrophic transport blockage to RGCs.5 Patients with glaucoma have increased levels of TGF-
β2 in their aqueous humor and raised TGF-β2 levels result in the pathological deposition of ECM 
proteins in human trabecular meshwork cells.5  
TGF-β2 expression has been shown to be increased in the human glaucomatous ONH by 
examining 4 age-matched normal and glaucomatous ONH tissues (figure 3).5 Compared to 
normal tissues, the glaucomatous ONH demonstrated increased TGF-β2 immunostaining (red) 
intensity merged with glial fibrillary acidic protein (GFAP).  Additionally, glaucomatous nerves 
had increased co-localization of the two in ONH (Figure 3B) and a the level of the LC (figure 
3C).5  
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The GFAP gene encodes for the construction of glial fibrillary acidic protein, responsible 
for binding together to form intermediate filaments found in astroglial cells.22 Zode et al. claimed 
to have presented the first results independently verifying increased immunohistochemical 
expression of TGF-β2 in the glaucomatous ONH.5 In vitro and in vivo findings from this 
research provided concluding evidence that TGF-β2 is involved in ECM remodeling by cells of 
the ONH in humans. Many studies assume that ONH astrocytes and LC cells are able to respond 
to elevated IOP by increasing TGF-β2 synthesis and secretion, which in turn alters ECM protein 




Figure 3. Immunohistochemical evaluation of transforming growth factor (TGF-β2 ) expression in age-
matched normal and glaucomatous optic nerve head (ONH) tissues. (A) ONH tissue section from a normal 
human donor. (B) ONH tissue sections from glaucomatous human eyes. (C, D) Showing part of the lamina 
cribrosa (LC) at a higher magnification. (E) Control (no primary antibody for TGF-β2 and GFAP) merged 
with DAPI in normal optic nerve head, and (F) in glaucoma-induced optic nerve head. (G) Relative 




Mediation of Gadd45b in Retinal Ganglion Cell Apoptosis 
Gadd45b is a growth arrest and DNA damage-inducible protein that is intrinsically 
expressed in retinal ganglion cells protecting RGCs from various neuronal pathologies, including 
glaucoma. Gadd45b is a mediator of the activation of the p38 mitogen-activated protein kinase 
pathway and its products are involved in regulation of growth and apoptosis.19  Yoo et al. 
identified Gadd45b as an effector of TGF-β-dependent apoptosis. Northern blot analysis of RNA 
isolated from AML12 murine hepatocytes underwent apoptosis as early as 8 hours following 
exposure to TGF- β detected by ELISA (figure 4A) and TUNEL assays (figure 4B). As shown in 
figure 4C, Gadd45b mRNA was present in these cells and was rapidly induced following 
treatment with TGF- β.19 Up-regulation of Gadd45b expression was found to be transcriptionally 
dependent, because the addition of actinomycin D, a transcription inhibitor, inhibited the TGF- β 
Gadd45b expression (Figure 4D). Therefore Gadd45b is an immediate early gene product of 
TGF- β cells in response to TGF- β induced apoptosis.19 
 
 
Figure 4. TGF- β induced apoptosis up-regulates Gadd45b expression. 4A and 4B: Induction of apoptosis 
in AML12 cells by TGF- β. DNA fragmentation was detected by ELISA (A) and TUNEL assay (B). (C)  
Northern blot analysis of Gadd45b RNA expression in AML12 cells stimulated with TGF- β for the 
indicated times. (D) Effect of cycloheximide or actinomycin on TGF- β induced Gadd45b expression in 
AML12 cells.  
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Smad Signaling in Retinal Ganglion Cells 
 Smads are a group of intracellular proteins that are responsible for delivering signals 
from TGF- β ligands to the cell nucleus.5 Neurotrophins and ECM proteins are synthesized by 
ONH astrocytes and LC cells in order to support RGC axons5. TGF-β2 dimers bind the type II 
receptor, resulting in transphosphorylation of the type I receptor. The activated type I receptor is 
responsible for phosphorylating Smads (Smad 2 and 3) and triggers heterodimerization with Co-
Smad4 and translocation of the complex to the nucleus which leads to activation of specific 
target genes.5,19  ONH astrocytes and LC cells have been concluded to possess autocrine TGF- 
β2 mediated Smad signaling. Zode et al. demonstrated the presence of TGF-β2, endogenous 
pSmad2 and 3 as well as their association with Co-Smad4 via co-localization.5 ONH astrocytes 
and LC cells incubated with TGF- β2 at specific time intervals and phosphorylation of Smad2 
and Smad3 was examined by western blot immunoassay. Recombinant TGF- β2 increased the 
phosphorylation of Smad2 and Smad3 in ONH astrocytes and LC cells compared to the 
controls.5 Figure 5A shows total Smad2, Smad3 and actin levels did not change upon treatment 
with TGF- β2. This suggests that TGF- β2 can activated Smad2/3 in ONH and LC cells.5 ONH 
astrocytes and LC cells were found to have autocrine TGF- β2 mediated Smad signaling.5  
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Figure 5. Effect of TGF- β2 on activation of Smad2/3 in optic nerve head (ONH) astrocytes and lamina 
cribrosa (LC) cells following TGF- β2 ncubation for 0, 15, 30, 60 and 120 minutes. (A) Cell lysates were 
analyzed for phosphorylated Smad3, total Smad3, phosphorylated Smad2, total Smad2 and actin. (B) ONH 
astrocytes and LC cells treated with or without TGF- β2 for 30, 60 and 120 minutes.  
 In contrast to Zode et al., recent studies suggest that p38 MAPK signaling is involved in 
apoptotic signaling in several cell types including RGCs.18,19,24,25 P38 mitogen-activated protein 
kinases (MAPKs) are a class of mitogen-activated protein kinases that are responsive to stress 
stimuli and involved in apoptosis. The p38 MAPK family consists of four main isoforms, 
designated; α, β, γ, and δ. The homologous p38α and β isoforms have been associated with CNS 
degeneration following ischemia, RGC injury, and in neonatal brain astrocyte apoptosis and 
oxidative stress.24,26,27 Little is known about p38 MAPK’s potential pro-apoptotic downstream 
targets.19 It has been reported that both Smad-dependent and Smad-independent pathways are 
capable of activating p38 MAPK.19 P38 MAPK activation is significant to induce TGF-β 
mediated apoptosis. The involvement of the p38 signaling pathway in TGF-β induced apoptosis 
in AML12 cells was studied by using a specific inhibitor of p38, SB203580. Increased p38 
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MAPK phosphorylation was strongly detected following the exposure to reactive oxidative stress 
(ROS) indicating its pro-apoptotic expression is up-regulated under stress.19,27  
Additional Mechanisms for Retinal Ganglion Cell Apoptosis 
Glutamate Cytotoxicity  
Glutamate is an amino acid that normally functions as a CNS neurotransmitter. However, 
it can become cytotoxic when its physiological concentrations are exceeded.28,29 It has been 
suggested that glutamate toxicity in retinal ganglion cells plays a role in the neuronal loss in 
glaucoma. Glaucoma selectively damages larger retinal ganglion cells first. Dreyer et al. sought 
to explore whether glutamate-mediated cell death was also more definite in larger RGCs. They 
found that glutamate is significantly more toxic to larger retinal ganglion cells in glaucoma.29 
Glutamate exerts its toxic effect on larger retinal ganglion cells by its N-methyl-D-aspartate 
subtype of glutamate receptor (NMDA) in tissue culture. More importantly, the same findings 
were more importantly reciprocated in RGCs of the intact normal non-glaucomatous rat eye. It 
was found that glutamate-mediated loss first effected larger RGCs, similar to the pattern loss 
identified in glaucoma.29 
Ocular Ischemic Syndrome 
In primates, blood moves from the periphery of the retina and optic nerve head to the 
single central retinal vein located in the center of the optic disc. This centripetal vascular supply 
pattern to the optic nerve predisposes the retina and optic nerve to ischemic disorders if 
obstruction of venous drainage occurs.10  
Patients with carotid atherosclerosis can present with ophthalmic symptoms. In 
atherosclerosis, thrombus formation from a ruptured atherosclerotic plaque can break off and 
travel distally into the ophthalmic artery. The thrombus can cause narrowing of the lumen and 
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chronic distal ischemia in the newly diseased vessel.30 The central retinal artery (CRA) is an end 
artery dividing into four major branches supplying non-overlapping sectors of the retina they 
supply.30 When an embolus enters the central retinal artery CRA causing occlusion, it tends to 
lodge in the narrowest portion of the artery at the lamina cribrosa which interferes with cellular 
signaling. More recently, retinal ischemia was induced by ligature in ophthalmic vessels of adult 
rats to investigate retrograde axonal transport in RGCs.31 This induced retinal ischemia was 
concluded to result in  glaucoma-like RGC loss and alterations of the retrograde axonal transport 
via surviving RGCs.31  
Mechanisms for Axonal Blockade Reversal 
Targeting TGF- β2 Downstream Signaling 
TGF- β2 and downstream signaling provided in vitro and in vivo evidence supporting the 
conclusion that TGF- β2 is in fact involved in ECM remodeling by cells of the ONH.5 The TGF- 
β2 driven ECM stimulation was concluded to require activation of recognized Smad signaling 
pathway. ECM proteins were stimulated in the ONH astrocytes and LC cells following the 
inhibition of type I TGF- β or knockdown of either Smad2 or Smad3 proteins. Therefore, 
inhibition of either of these downstream signals may prove to be a vital therapeutic target to 
prevent ECM remodeling present in the ONH under glaucomatous conditions.5  
Antibody-Mediated TrkB Agonism  
Brain-derived neurotrophic factor (BDNF) is a neurotransmitter modulator that plays a 
significant role in supporting differentiation, maturation and neuron survival.14 BDNF signaling 
pathways activated transcription factors are important for the regulated gene expression for genes 
encoding proteins involved in neural plasticity, stress resistance and cell survival. TrkB receptor 
dimerization results from the ligand, BDNF binding and the auto-phosphorylation of the tyrosine 
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residues. This provides a docking site for src-homology 2-domain containing adaptor protein 
(Shc) and phospholipase C (PLC).14 Bathina et al. concluded guanine nucleotide-releasing factor 
SOS binds SHC to the adapter protein, Grb2. Ras is linked to Grb2 by SOS and activates 
numerous cell signaling pathways: Ras/MAPK-ERK pathway, PI3-K pathway and PLC 
pathway.14    
BDNF mRNA expression is strikingly reduced in the visual cortex by monocular 
deprivation.14 Anti-BDNF antiserum and TrkB-IgG construct have been found to successfully 
antagonize the action of BDNF in neurotrophic pain and inflammatory hypersensitivity. These 
findings validated the potential for antibody-mediated TrkB agonism as a potential therapeutic 
approach to enhance RGCs survival after optic nerve damage.14 In a trauma induced central 
nervous system model, and in vivo injection of BDNF in an adult rat retinal ganglion cell 
enhanced neuronal survival.14 These studies suggest that BDNF is correlated with prompting 
RGC survival and if signaling is blocked, stress resistance and cell survival is reduced. 
Conclusion 
In conclusion, the pathophysiology of glaucoma is complex, and multiple downstream 
signaling cascades are involved in the development of retinal ganglion cell apoptosis at the level 
of the optic nerve head. The transforming growth factor-β-dependent apoptosis signaling 
pathway, Gadd45b and p38 MAPK all play critical roles in glaucomatous neuropathy. Additional 
mechanisms of disease, including glutamate cytotoxicity and ocular ischemic syndrome, produce 
glaucomatous-like neuropathy on the RGCs of the optic nerve head. Significantly, inhibition of 
type I TGF- β or knockdown of either Smad2 or Smad3 proteins may prove to be therapeutic 
targets to prevent ECM remodeling present in the ONH under glaucomatous conditions. 
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Additionally, the potential for antibody-mediated TrkB agonism to induce BDNF expression 
may be a therapeutic approach to enhance RGC survival following optic nerve damage.  
Implications 
 The implications of the review expand on how glaucoma should not be confined as a 
disease solely of the ocular system, but as a disease of pressure differences throughout the body 
altering downstream signaling. A translaminar pressure difference is capable of inducing optic 
nerve head changes that affect retrograde axonal transport and ultimately interfere with retinal 
ganglion cell signaling. The review illustrates a potential mechanistic downstream signaling 
cascade that plays a critical role in retinal ganglion cell apoptosis in glaucoma. Furthermore, 
research involving cellular mechanisms responsible for glaucoma and retinal ganglion cell 
apoptosis are promptly evolving in the science community. Further research in the efforts of 
discovering mechanistic details responsible for glaucoma in order to identifying targets for 
reversing retinal ganglion cell death or translaminar pressure differences is of priority to evolve 
disease prevention.     
Limitations 
 An ongoing issue that continues to hinder understanding the mechanism of RGC death in 
glaucoma and development of RGC therapeutics is the lack of a reliable RGC model. A reliable 
model would be used to facilitate in vitro screening of potential neurotrophic factors or 
therapeutic delivery systems in an efficient and cost-effective manner. Primary RGCs would 
ideally be isolated from post-mortem human retinas. Alternatively, mice or monkeys could serve 
as models. However, studying ONH tissue samples are limited in the low abundance of RGCs 
present in the retina, the difficult of efficient isolation, and more importantly, the short duration 
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of isolated RGC cultures in vitro limits the range of testing and applications that can be 
performed using these primary cells. A reliable immortalized RGC line is urgently needed.  
Future Research 
 Considering all experimental evidences, translaminar gradient should be regarded as a 
significant area of future research. Studies in animal models and human optic nerve head 
samples will potentially allow for the relationship between ICP, IOP and glaucoma to be defined. 
Standardizing non-invasive and surrogate techniques to identify ICP values will be of 
significance since current methods are invasive. Future research focused on obtaining the ability 
to visualize the translaminar gradient change in optic nerve heads a the lamina cribrosa under 
glaucomatous conditions should correlate with identifying changes in neurotrophic signaling. 
This could lead to the development of understanding which specific cell type to target 
downstream the glaucoma apoptotic cell signaling mechanism to prevent continued RGC death 
and potentially reverse its damaging effects.   
References and Notes 
1.  Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39-57. 
doi:10.1016/S1350-9462(98)00014-7 
2.  Cook C, Foster P. Epidemiology of glaucoma: what’s new? Can J Ophthalmol. 
2012;47(3):223-226.  
3.  Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. 
Prog Retin Eye Res. 2000;19(3):297-321.  
4.  Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and 
their relation to glaucomatous optic nerve damage. Arch Ophthalmol Chic Ill 1960. 
1981;99(1):137-143. 
5.  Zode GS, Sethi A, Brun-Zinkernagel A-M, Chang I-F, Clark AF, Wordinger RJ. 
Transforming growth factor-β2 increases extracellular matrix proteins in optic nerve head 
cells via activation of the Smad signaling pathway. Mol Vis. 2011;17:1745-1758. 
Glaucoma 21 
6.  Jonas JB, Berenshtein E, Holbach L. Anatomic Relationship between Lamina Cribrosa, 
Intraocular Space, and Cerebrospinal Fluid Space. Investig Opthalmology Vis Sci. 
2003;44(12):5189.  
7.  Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial Pressure in Primary Open 
Angle Glaucoma, Normal Tension Glaucoma, and Ocular Hypertension: A Case–Control 
Study. Investig Opthalmology Vis Sci. 2008;49(12):5412.  
8.  WH Morgan, Yu D, RL Cooper, Alder V, Cringle S, Constable I. The influence of 
cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradien. Invest 
Ophthalmol Vis Sci. 1995.  
9.  Albon J. Age related compliance of the lamina cribrosa in human eyes. Br J Ophthalmol. 
2000;84(3):318-323.  
10.  Brooks, Komaromy, Kallberg. Comparative optic nerve physiology: implications for 
glaucoma, neuroprotection, and neuroregeneration. Vet Ophthalmol. 1999;2(1):13-25.  
11.  Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal Fluid Pressure Is Decreased in 
Primary Open-angle Glaucoma. Ophthalmology. 2008;115(5):763-768.  
12.  Ren R, Jonas JB, Tian G, et al. Cerebrospinal Fluid Pressure in Glaucoma. Ophthalmology. 
2010;117(2):259-266.  
13.  O’Sullivan ML, Puñal VM, Kerstein PC, et al. Astrocytes follow ganglion cell axons to 
establish an angiogenic template during retinal development: O’SULLIVAN et al. Glia. 
2017;65(10):1697-1716.  
14.  Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med 
Sci AMS. 2015;11(6):1164-1178.  
15.  Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion 
cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest 
Ophthalmol Vis Sci. 1995;36(5):774-786. 
16.  Shen, Wiemelt, Mcmorris, Barres. Retinal Ganglion Cells Lose Trophic Responsiveness 
after Axotomy. Neuron. 1999;23(2):285-295. 
17.  Purves D. Body and Brain: A Trophic Theory of Neural Connections. Cambridge, Mass: 
Harvard University Press; 1988. 
18.  Dapper J, Calkins, David. p38 MAPK Activation in Rodent Retina with Glaucoma-Relevant 
Stressors. Invest Ophthalmol Vis Sci. 2012;53, 3846(14). 
19.  Yoo J, Ghiassi M, Jirmanova L, et al. Transforming Growth Factor-β-induced Apoptosis Is 
Mediated by Smad-dependent Expression of GADD45b through p38 Activation. J Biol 
Chem. 2003;278(44):43001-43007.  
Glaucoma 22 
20.  Hsing AY, Kadomatsu K, Bonham MJ, Danielpour D. Regulation of Apoptosis Induced by 
Transforming Growth Factor-β1 in Nontumorigenic and Tumorigenic Rat Prostatic 
Epithelial Cell Lines. Cancer Res. 1996;56(22):5146. 
21.  Dünker N, Schuster N, Krieglstein K. TGF-beta modulates programmed cell death in the 
retina of the developing chick embryo. Dev Camb Engl. 2001;128(11):1933-1942. 
22.  Tanihara H, Hangai M, Sawaguchi S, et al. Up-regulation of Glial Fibrillary Acidic Protein 
in the Retina of Primate Eyes With Experimental Glaucoma. Arch Ophthalmol. 
1997;115(6):752-756.  
23.  Liu B, Sun X, Suyeoka G, Garcia JGN, Leiderman YI. TGFβ Signaling Induces Expression 
of Gadd45b in Retinal Ganglion Cells. Investig Opthalmology Vis Sci. 2013;54(2):1061.  
24.  Kikuchi M, Tenneti L, Lipton SA. Role of p38 Mitogen-Activated Protein Kinase in 
Axotomy-Induced Apoptosis of Rat Retinal Ganglion Cells. J Neurosci. 2000;20(13):5037-
5044.  
25.  Inoue-Mochita M, Inoue T, Fujimoto T, et al. p38 MAP kinase inhibitor suppresses 
transforming growth factor-β2-induced type 1 collagen production in trabecular meshwork 
cells. PloS One. 2015;10(3):e0120774.  
26.  Sugino T, Nozaki K, Takagi Y, et al. Activation of Mitogen-Activated Protein Kinases after 
Transient Forebrain Ischemia in Gerbil Hippocampus. J Neurosci. 2000;20(12):4506-4514.  
27.  Nahirnyj A, Livne-Bar I, Guo X, Sivak JM. ROS Detoxification and Proinflammatory 
Cytokines Are Linked by p38 MAPK Signaling in a Model of Mature Astrocyte Activation. 
Stangel M, ed. PLoS ONE. 2013;8(12):e83049.  
28.  Schori H, Kipnis J, Yoles E, et al. Vaccination for protection of retinal ganglion cells against 
death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma. 
Proc Natl Acad Sci. 2001;98(6):3398-3403.  
29.  Dreyer EB, Pan ZH, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells 
to NMDA-mediated cell death. Neuroreport. 1994;5(5):629-631. 
30.  Arthur A, Alexander A, Bal S, Sivadasan A, Aaron S. Ophthalmic masquerades of the 
atherosclerotic carotids. Indian J Ophthalmol. 2014;62(4):472-476.  
31.  Lafuente López-Herrera M. Transient Ischemia of the Retina Results in Altered Retrograde 
Axoplasmic Transport: Neuroprotection with Brimonidine. Exp Neurol. 2002;178(2):243-
258.  
32.  Causin P, Guidoboni G, Harris A, Prada D, Sacco R, Terragni S. A poroelastic model for the 
perfusion of the lamina cribrosa in the optic nerve head. Math Biosci. 2014;257:33-41.  
Glaucoma 23 
Acknowledgements 
The author would like to thank Dr. John P. Berdahl for his time and effort to externally 
review this paper and provide structural criticism and suggestions to strengthen the review. Dr. 
Berdahl’s advice and encouragement was vital in the success of the paper. His passion for 
understanding the material extensively and drive to push the boundaries of ones understanding of 
glaucoma especially motivated me to do the same in my research. Additionally, the author would 
like to thank Dr. David Stephens for conceptual feedback, clinical insight, and manuscript 
review. The author also thanks Rachel Scott for literature suggestions and helpful annotations, 
Dr. Greg Heiberger and her fellow peers for guidance, recommendations and inspiration 
throughout this process.  
Funding 
The author received no specific funding for this work. 
Competing Interests 
No competing interests are declared by the author.  
Data and Materials Availability 
The author proclaims no competing interest.  
Supplementary Methods 
External reviewer feedback from Dr. John P. Berdahl from Vance Thompson Vision, in 
Sioux Falls, SD, included a lesson on the current mechanistic understanding of axonal blockade 
due to translaminar pressure gradient. Background information on glaucoma as well as 
interference of the translaminar gradient experienced during space flight were explained. The 
author would like to thank Dr. David Stephens for providing impeccable feedback improving the 
order of topics discussed. Beneficial feedback included grammatical, formatting, and 
Glaucoma 24 
organization techniques as well as encouragement to better refine the scope of the paper. Rachel 
Anne Scott, M.D. student, noted significant articles for topic review that were also in her own 
literature search of the topic. I appreciatively accepted the feedback received and used it to 













Figure A- 1:  Left: Anatomy of the optic nerve head regions with the lamina cribrosa. Right: microscale 

























Acronyms and Abbreviations 
RGC Retinal ganglion cell 
ONH Optic nerve head 
LC  Lamina cribrosa 
IOP Intraocular pressure 
ICP Intracranial pressure 
ON Optic nerve 
CSFp Cerebrospinal fluid pressure 
OPP Ocular perfusion pressure 
TLPD Translaminar pressure difference 
NTG Normal tension glaucoma 
POAG Possible open angle glaucoma 
RNF Retinal nerve fiber 
RNFL Retinal nerve fiber layer 
PGI2 Prostacyclin 
cAMP Cyclic adenosine 3’,5’-monophosphate 
ET-1 Endothelin-1 
CNS Central nervous system 
MAPK mitogen-activated protein kinase 
TGF- β2 Transforming growth factor-β2 
ECM Extracellular matrix 
GFAP Glial fibrillary acidic protein 
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Gadd Growth arrest and DNA damage-
inducible protein 
TUNEL Terminal deoxynucleotidyl transferase 
dUTP nick end labeling 
AML Alpha mouse live 
NMDA N-methyl-D-aspartate subtype of 
glutamate receptor 
BDNF Brain-derived neurotrophic factor 
 
